Zum Hauptinhalt springen

catechol-O-methyltransferase

Der COMT gene provides instructions for making an enzyme called catechol-O-methyltransferase. Two versions of this enzyme are made from the gene. The longer form, called membrane-bound catechol-O-methyltransferase (MB-COMT), is chiefly produced by nerve cells in the brain. Other tissues, including the liver, kidneys, and blood, produce a shorter form of the enzyme called soluble catechol-O-methyltransferase (S-COMT). This form of the enzyme helps control the levels of certain hormones.

Normal function

Der COMT gene provides instructions for making an enzyme called catechol-O-methyltransferase. Two versions of this enzyme are made from the gene. The longer form, called membrane-bound catechol-O-methyltransferase (MB-COMT), is chiefly produced by nerve cells in the brain. Other tissues, including the liver, kidneys, and blood, produce a shorter form of the enzyme called soluble catechol-O-methyltransferase (S-COMT). This form of the enzyme helps control the levels of certain hormones.

In the brain, catechol-O-methyltransferase helps break down certain chemical messengers called neurotransmitters. These chemicals conduct signals from one nerve cell to another. Catechol-O-methyltransferase is particularly important in an area at the front of the brain called the prefrontal cortex, which organizes and coordinates information from other parts of the brain. This region is involved with personality, planning, inhibition of behaviors, abstract thinking, emotion, and working (short-term) memory. To function efficiently, the prefrontal cortex requires signaling by neurotransmitters such as dopamine and norepinephrine. Catechol-O-methyltransferase helps maintain appropriate levels of these neurotransmitters in this part of the brain.

Conditions referring to this gene or chromosome

Other names

Catechol Methyltransferase

COMT_HUMAN

Related patient information and medicines

Parkinson-Krankheit

Patient information leaflet

Parkinson-Krankheit

Parkinson's disease is a progressive neurological degeneration of certain cells (called dopaminergic cells) within a specific part of the brain (substantia nigra). The deficiency of dopamine leads to a movement disorder with Parkinson's disease symptoms. Sometimes these medicines are used in combination with levodopa in the later stages of PD..

Tolcapon bei Parkinson-Krankheit

Medicine leaflet

Tolcapon bei Parkinson-Krankheit

Tolcapone will be recommended for you by a specialist doctor who will continue to check on your progress. You should tell your doctor immed... About tolcapone Type of medicine A dopaminergic medicine called a catechol-O-methyltransferase inhibitor Verwendet für Parkinson-Krankheit Also called Tasmar® Available as Tablets Parkinson's disease affects the.

Entacapon bei Parkinson-Krankheit

Medicine leaflet

Entacapon bei Parkinson-Krankheit

Entacapone will be recommended for you by a specialist doctor who will continue to check on your progress. About entacapone Type of medicine A dopaminergic medicine called a catechol-O-methyltransferase inhibitor Used for Parkinson's disease Also called Comtess®; Combination brands: Stalevo®, Sastravi®, Stanek®, Lecigon® (entacapone with levodopa.

Tioguanin

Medicine leaflet

Tioguanin

You will be prescribed tioguanine by a doctor who specialises in cancer treatment. Tioguanine is a treatment used for acute myeloid leukaemia (AML) , acute lymphoblastic leukaemia (ALL) , and chronic myeloid leukaemia (CML). If you have ever been told by a doctor that you lack certain enzymes... In particular, tell your doctor if you know your.

Mercaptopurin

Medicine leaflet

Mercaptopurin

You will be prescribed mercaptopurine by a specialist cancer doctor. About mercaptopurine Type of medicine An antimetabolite anti-cancer medicine Used for Treatment of leukaemia Also called Xaluprine®; Hanixol® Available as Tabl... Mercaptopurine is a treatment used for acute myeloid leukaemia (AML) , acute lymphoblastic leukaemia (ALL) , and.

Weiterführende Lektüre und Referenzen

Artikelverlauf

Die Informationen auf dieser Seite werden von qualifizierten Klinikern verfasst und begutachtet.
  • 24 Mar 2026 | Neueste Version
  • 1 Sept 2007 | Ursprünglich veröffentlicht

Nehmen Sie an der Diskussion teil

Teilen Sie Ihre Gedanken oder Erfahrungen mit anderen in unserem Patientengemeinschaften.

Haftungsausschluss: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.
Grippe-Berechtigungsprüfer

Fragen, teilen, verbinden.

Durchsuchen Sie Diskussionen, stellen Sie Fragen und teilen Sie Erfahrungen zu Hunderten von Gesundheitsthemen.

Abonnieren Sie den Patienten-Newsletter

Ihre wöchentliche Dosis klarer, vertrauenswürdiger Gesundheitsberatung - geschrieben, um Ihnen zu helfen, sich informiert, selbstbewusst und in Kontrolle zu fühlen.

Bitte geben Sie eine gültige E-Mail-Adresse ein

Durch das Abonnieren akzeptieren Sie unsere Datenschutzrichtlinie. Sie können sich jederzeit abmelden. Wir verkaufen Ihre Daten niemals.